Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0008180 | COP9 signalosome | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A4H4A3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 18 | 22 | PF00656 | 0.532 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.719 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.556 |
DOC_CKS1_1 | 113 | 118 | PF01111 | 0.519 |
DOC_CYCLIN_RxL_1 | 66 | 77 | PF00134 | 0.574 |
DOC_CYCLIN_RxL_1 | 93 | 104 | PF00134 | 0.547 |
DOC_MAPK_gen_1 | 98 | 105 | PF00069 | 0.456 |
DOC_PP1_RVXF_1 | 67 | 74 | PF00149 | 0.577 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.645 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.676 |
DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.594 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.403 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.614 |
DOC_WW_Pin1_4 | 170 | 175 | PF00397 | 0.562 |
LIG_14-3-3_CanoR_1 | 163 | 168 | PF00244 | 0.635 |
LIG_BRCT_BRCA1_1 | 33 | 37 | PF00533 | 0.599 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.744 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.694 |
LIG_FHA_2 | 16 | 22 | PF00498 | 0.649 |
LIG_FHA_2 | 171 | 177 | PF00498 | 0.546 |
LIG_FHA_2 | 73 | 79 | PF00498 | 0.584 |
LIG_LIR_Gen_1 | 104 | 113 | PF02991 | 0.668 |
LIG_LIR_Nem_3 | 104 | 108 | PF02991 | 0.595 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.597 |
LIG_MLH1_MIPbox_1 | 33 | 37 | PF16413 | 0.599 |
LIG_NRBOX | 66 | 72 | PF00104 | 0.573 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.538 |
LIG_SH2_NCK_1 | 175 | 179 | PF00017 | 0.402 |
LIG_SH2_SRC | 175 | 178 | PF00017 | 0.428 |
LIG_SH2_SRC | 190 | 193 | PF00017 | 0.455 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.564 |
LIG_SH3_3 | 110 | 116 | PF00018 | 0.589 |
LIG_SUMO_SIM_anti_2 | 60 | 69 | PF11976 | 0.543 |
LIG_TYR_ITIM | 121 | 126 | PF00017 | 0.552 |
LIG_WRC_WIRS_1 | 102 | 107 | PF05994 | 0.583 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.554 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.676 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.500 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.655 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.388 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.721 |
MOD_N-GLC_1 | 170 | 175 | PF02516 | 0.562 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.547 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.593 |
MOD_NEK2_2 | 82 | 87 | PF00069 | 0.397 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.507 |
MOD_PIKK_1 | 107 | 113 | PF00454 | 0.550 |
MOD_PIKK_1 | 88 | 94 | PF00454 | 0.676 |
MOD_Plk_1 | 31 | 37 | PF00069 | 0.594 |
MOD_Plk_4 | 101 | 107 | PF00069 | 0.524 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.621 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.478 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.615 |
MOD_ProDKin_1 | 170 | 176 | PF00069 | 0.556 |
TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.593 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.539 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I8M2 | Leptomonas seymouri | 45% | 85% |
A0A3Q8IF59 | Leishmania donovani | 82% | 100% |
A0A3R7KB37 | Trypanosoma rangeli | 21% | 96% |
A4I182 | Leishmania infantum | 82% | 100% |
D0A5G6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 22% | 99% |
E9AXB6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4QA56 | Leishmania major | 82% | 100% |